| Literature DB >> 9489740 |
Y Du1, K R Bales, R C Dodel, X Liu, M A Glinn, J W Horn, S P Little, S M Paul.
Abstract
Beta-amyloid peptides (A beta) are deposited in an aggregated fibrillar form in both diffuse and senile plaques in the brains of patients with Alzheimer's disease. The neurotoxicity of A beta in cultured neurons is dependent on its aggregation state, but the factors contributing to aggregation and fibril formation are poorly understood. In the present study, we investigated whether alpha2-macroglobulin (alpha2M), a protein present in neuritic plaques and elevated in Alzheimer's disease brain, is a potential regulatory factor for A beta fibril formation. Previous studies in our laboratory have shown that alpha2M is an A beta binding protein. We now report that, in contrast to another plaque-associated protein, alpha1-antichymotrypsin, alpha2M coincubated with A beta significantly reduces aggregation and fibril formation in vitro. Additionally, cultured fetal rat cortical neurons are less vulnerable to the toxic actions of aged A beta following pretreatment with alpha2M. We postulate that alpha2M is able to maintain A beta in a soluble state, preventing fibril formation and associated neurotoxicity.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9489740 DOI: 10.1046/j.1471-4159.1998.70031182.x
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372